baber/WOPTO huggingface dataset:
Patent JP-2611816-B2 (JP)
IPC: C07C229/42
Filed: 1988-08-12
Granted: 1997-05-21
Abstract: Process for the preparation of compounds of formula 
<IMAGE>
 in which X denotes hydrogen, a halogen, a trifluoromethyl group or a lower alkyl group; W denotes methyl, Q denotes hydrogen or W and Q together form an ethylene group and R' denotes a lower alkyl group, characterised in that the amino group of the phenol corresponding to the compound of formula I is protected, the compound thus obtained is subjected to an alkylation with a compound of formula Hal-CH2-COOR', where R' is as defined in the case of formula I and Hal is chlorine, bromine or iodine, and the amino group of the product thus obtained is then deblocked.
Patent JP-H0255432-B2 (JP)
IPC: C07D401/06
Filed: 1984-10-05
Abstract: Mefloquin hydrochloride in the form of modification E as characterized by IR spectrum and X-ray diffraction pattern, as well as a process for the preparation thereof by treating mefloquin hydrochloride, comprising at least partially another modification, that is, mefloquin hydrochloride which is not pure mefloquin hydrochloride in the form of modification E, with methanol and/or ethanol, in the presence of less than 30 volume/percent of water.
Patent JP-3174405-B2 (JP)
IPC: C07D405/14
Filed: 1992-07-17
Granted: 2001-06-11
Abstract: The invention relates to novel 8-vinyl- and 8-ethynyl- quinolonecarboxylic acids, a process for their preparation and antibacterial agents and feed additives containing them.
Patent JP-H0672294-B2 (JP)
IPC: C22C38/60
Filed: 1985-10-15
Abstract: Cast metal parts such as turbocharger housings which are subject to operating temperatures up to about 2000 DEG F (1093 DEG C) and require good thermal cyclic durability (resistance to thermal cracking) and burst containment properties, are made from a low nickel duplex stainless steel with nitrogen addition by the use of grey and ductile iron casting technology.
Patent JP-2591287-B2 (JP)
IPC: F16D65/18
Filed: 1990-08-31
Granted: 1997-03-19
Abstract: PURPOSE:To make the facing repair of a disc rotor possible in the state of a loaded car by providing a fixing mechanism for fixing a cylinder body to a torque member when a brake pad has been exchanged for a grinding pad in a disc brake whose cylinder body slides in the direction of an axle. CONSTITUTION:In the case where a facing work is carried out on a disc rotor 2, a tire is removed, and a brake pad 7 is exchanged for a grinding pad 8, which is connected to a hydraulic pressure source 31. After a brake unit having the disc rotor 2, a torque member 4 and a cylinder body 6 is then clamped for its positioning, the grinding pad 8 is pressed against the disc rotor 2 by the hydraulic pressure of the hydraulic pressure source 31. Fixing bolts 9e are inserted into the slot 9d of a fixing mechanism 9 to temporarily fix the cylinder body 6 to the torque member 4, and the disc rotor 2 is rotated through an exclusive motor for grinding its surface. Thus the disc rotor 2 can be easily ground without removing it from a car.
Patent JP-H07103958-B2 (JP)
IPC: F17C7/00
Filed: 1990-09-06
Abstract: Method and apparatus for supplying gas, especially a cryogenic gas, to a use point (1) at high pressure, especially supercritical pressure, with little or no lag time comprising a gas supply (6-9) for quickly pressurizing a vaporizable liquid (10, 11) and the vaporization (26) of the pressurized liquid for high pressure gas supply.
Patent JP-3280777-B2 (JP)
IPC: B29C48/21
Filed: 1993-09-21
Granted: 2002-05-13
Abstract: Tubular, biaxially stretched, heat shrinkable multilayer film food casings comprising inner and outer polyamide layers on either side of a core layer predominantly of one or more ethylenic polymers having a functional moiety selected from the group of esters, anhydrides, and carboxylic acids, and a coextrusion process for making the film. <IMAGE>
Patent JP-2601008-B2 (JP)
IPC: A61P25/26
Filed: 1990-10-25
Granted: 1997-04-16
Abstract: A naphthyloxazolidone derivative of the formula: <CHEM> wherein R<1> is hydrogen atom, hydroxy group, nitro group, amino group, sulfo group, aminosulfonyl group, a lower alkenyloxy group, a lower alkynyloxy group, a mono or di(lower alkyl)aminocarbonyloxy group, a lower alkanoyloxy group or a lower alkoxy group which may have a substituent selected from an aryl group, a cycloalkyl group, an oxygen-containing heteromonocyclic group, hydroxy group, a lower alkoxy group, cyano group, a di(lower alkyl)amino group, aminocarbonyl group, a lower alkoxycarbonyl group, a lower alkanoyloxy group, a lower alkylthio group, a lower alkylsulfinyl group and a lower alkylsulfonyl group; R<2> is hydroxy group, a lower alkoxy group, a lower alkylsulfonyloxy group, triazo group or an amino group which may have a substituent selected from a lower alkyl group and a lower alkanoyl group, and a pharmaceutically acceptable salt thereof are disclosed. Said derivative and a pharmaceutically acceptable salt thereof lare useful as an antidepressant.
Patent JP-H0832582-B2 (JP)
IPC: B32B13/04
Filed: 1990-10-30
Abstract: Composite structures of ceramic material and super concrete. The structures comprises an outer layer of ceramic material bonded to an internal structure of super concrete or an outer structure of super concrete bonded to an inner layer of ceramic material The ceramic material is selected from inorganic or metallic products which are subjected to a temperature of 540 DEG C and above during manufacture or use, while the super concrete comprises densely packed particles of inorganic materials embedded in a matrix based on an hydraulic cement and having a strength of at least 70 MPa.
Patent JP-2950422-B2 (JP)
IPC: C23C16/30
Filed: 1988-12-28
Granted: 1999-09-20
Abstract: A metal oxide is provided which comprises bismuth, an alkaline earth metal, copper and oxygen, wherein the metal oxide material further comprises at least one element selected from the group consisting of lanthanoid elements and yttrium. As a preferred embodiment, a metal oxide material is provided which is represented by the compositional formula: LnxBiyAzCuO delta , wherein Ln is at least one element selected from the group consisting of lanthanoid elements and yttrium; A is at least one element selected from alkaline earth metals; and 0.01 </= x </= 0.5, 0.5 </= y < 3, 0.5 </= z < 3, and 4 < delta .
Patent JP-H0661426-B2 (JP)
IPC: B01J23/28
Filed: 1990-11-29
Abstract: A process for the removal of sulfur dioxide from gasses produced by processes resulting in off gases at elevated temperatures as in the combustion of sulfur containing fuels such as coal and fuel oil by contacting the gasses with a composition including a source of calcium, and a catalytically effective amount of a molybdenum containing catalyst for the oxidation of sulfur dioxide to sulfur trioxide which then reacts with the calcium compound to form calcium sulfate.
Patent JP-2970160-B2 (JP)
IPC: H04W84/10
Filed: 1991-11-30
Granted: 1999-11-02
Abstract: PURPOSE:To enlarge a call area and to improve call tone quality in response to diversified user needs in a codeless telephone set. CONSTITUTION:Means 18 and 19 for altering a minimum electric level, a means transmitting the altered minimum electric field level to a connection device 20 and a means 16 measuring an input electric field level are provided for the codeless telephone set 10. A means 26 measuring the input electric field level is provided for the connection device 20. Thus, the minimum electric field level can be dropped when a user intends to enlarge the call area, and the minimum electric field level can be raised when the user intends to improve call tone quality.
Patent JP-3606882-B2 (JP)
IPC: H04Q7/24
Filed: 1998-04-14
Granted: 2005-01-05
Abstract: A method and an apparatus for transmitting a continuous data stream in packetized form include a storage device in which the data can be temporarily stored for specific times before and after their transmission. The data are temporarily stored in a cyclic buffer. Therefore, the complexity to be accepted for error-free data transmission can be minimized.
Patent JP-3955322-B2 (JP)
IPC: B29C43/00
Filed: 1996-06-04
Granted: 2007-08-08
Abstract: An article which comprises (1) a composite comprising a polyurethane matrix including fibrous or particulate reinforcement, the polyurethane matrix being formed in situ about the reinforcement by reaction of polyurethane forming components at a temperature below the melting point of the reinforcement and (2) a polymeric film bound to at least one surface of the composite, the film being bound to the composite by adhesion to the polyurethane matrix which emerges or is enhanced as the matrix is formed in situ.
Patent JP-H0366881-B2 (JP)
IPC: A47B57/56
Filed: 1982-06-23
Abstract: A load support system including a plurality of cantilever shelf elements each having a selectively shaped and oriented bracket assembly at one end thereof for conjointly permitting vertical displacement of the cantilever shelf elements relative to a vertical standard and locking thereof in selected load-bearing location in response to angular disposition of said shelf element relative to said standard.
Patent JP-3827726-B2 (JP)
IPC: A61L29/16
Filed: 1996-06-06
Granted: 2006-09-27
Abstract: The invention features a method for triggering release of a drug from a hydrogel polymer to tissue at a desired location of the body using a catheter. A portion of the catheter is coated on its outer surface with a polymer having the capacity to incorporate a predetermined substantial amount of drug which is immobilized in the polymer until released by a triggering agent or condition that is different from physiological conditions. Upon contact with a triggering agent or condition, the polymer reacts, e.g., swells or contracts, such that the drug is delivered to the desired body tissue. A balloon catheter is shown in which the hydrogel is carried on the exterior surface of the balloon.
Patent JP-3394257-B2 (JP)
IPC: A61P25/16
Filed: 1994-06-15
Granted: 2003-04-07
Abstract: The present invention relates to the use of efaroxan and its derivatives for the preparation of a medicinal product intended for the treatment of Parkinson's disease.
Patent JP-3234599-B2 (JP)
IPC: A61M15/00
Filed: 1992-08-20
Granted: 2001-12-04
Abstract: A device for triggering a mechanical switching process in inhalers in synchronicity with breathing has a membrane-like sensor element (47) that cooperates with a triggering mechanism (45, 46, 50) on a switching device (13, 19c, 22).
Patent JP-2522737-B2 (JP)
IPC: H04M9/08
Filed: 1991-01-22
Granted: 1996-08-07
Abstract: A process to reduce the howl condition in a radiotelephone when the microphone picks up audio from the speaker. The condition is detected by first lowering the speaker volume (103) and measuring the microphone volume for a corresponding decrease (104). The speaker volume is then increased (105) and the microphone volume is again measured for a corresponding increase (106). If the microphone volume follows the speaker volume, a howl condition has been detected. To eliminate the condition without the volume fluctuations being noticed by the parties conversing, the microphone and speaker volume is reduced in small increments (114) until the condition is eliminated.
Patent JP-2769486-B2 (JP)
IPC: H04B3/23
Filed: 1987-09-01
Granted: 1998-06-25
Abstract: A linear predictive echo canceller is integrated with a RELP vocoder in a two-way communications network, in which a received digitized speech signal synthesized by the RELP vocoder from a residual signal received with linear prediction coefficients is echoed onto a transmit channel and combined with a transmitted digitized speech input signal that is to be analyzed by a RELP vocoder for transmission. The echo canceller cancels the echoed signal from the transmit channel by generating a foreground transmit signal by subtracting a foreground estimate of the echoed signal from the combined signal; and providing the foreground transmit signal on the transmit channel for ananlysis by the RELP vocoder. In order to generate the foreground transmit signal, the echo canceller filters the received digitized speech signal with adaptation coefficients to generate the foreground estimate of the echoed signal; prewhitens the foreground transmit signal by using the received linear prediction coefficients; and generates the adaptation coefficients by cross correlating the received residual signal with the prewhitened foreground transmit signal and adding the product of said cross correlation to the adaptation coefficients used for generating the foreground estimate of the echoed signal.
Patent JP-3835817-B2 (JP)
IPC: A61M5/172
Filed: 1996-09-06
Granted: 2006-10-18
Abstract: A medication injection mechanism, for delivering a dosage of medication from a medication cartridge having a piston, includes a two-piece drive shaft, a rachet mechanism, and a drive mechanism. The two-piece drive shaft includes a plunger portion and a drive portion. The plunger portion has an end that contacts the piston of the medication cartridge, ratchet teeth disposed on the sides of the plunger portion that define a thickness of the plunger portion, and an opening to provide a passage through the plunger portion of the two-piece drive shaft. The drive portion is formed by rails that are coupled together by a connector that passes through the opening in the plunger portion so that the drive portion is coupled to the plunger portion, and can move relative to the plunger portion. Each of the rails forming the drive portion has threads on a surface that extend beyond the defined thickness of the plunger portion. The ratchet mechanism engages with the ratchet teeth of the plunger portion to permit the movement of the plunger portion toward the piston of the medication cartridge and to inhibit movement of the plunger portion away from the piston of the medication cartridge. Also, the drive mechanism engages with the threads on the rails of the drive portion, but is free of contact with the ratchet teeth on the plunger portion to adjust the position of the drive portion relative to the plunger portion so that the drive portion can be moved toward the piston of the medication cartridge a fixed distance and the plunger portion is moved a distance that is less than or equal to the fixed distance.
Patent JP-3237016-B2 (JP)
IPC: A61L15/00
Filed: 1993-10-27
Granted: 2001-12-10
Abstract: The invention concerns a transdermal therapeutic system comprising the active substance 17- beta -estradiol and optionally further active substances, with a laminated structure comprising a backing layer which is substantially impermeable to moisture and impermeable to active substance, one or more matrix layers and, where non-adhesive matrix layers are present, an adhesive layer, characterized in that the concentration of the dissolved estradiol in all matrix layers and, where an adhesive layer is present, in the adhesive layer lies between its saturation concentration in dry condition und its saturation concentration in moist condition, whereby the term "dry condition" is understood to mean that the base material is in equilibrium with a gas phase with less than 10% relative humidity and the term "moist condition" is understood to mean that the base material is in equilibrium with a gas phase with more than 90% relative humidity.
Patent JP-3990447-B2 (JP)
IPC: A61K9/50
Filed: 1995-10-10
Granted: 2007-10-10
Abstract: A process is described for preparing microspheres, films and coatings from protein or modified protein in which the protein product is stabilized by carrying out the preparation in the presence of an aqueous solution of at least one alpha-hydroxy acid. Preferred alpha-hydroxy acids are glycolic acid, lactic acid, alpha-hydroxybutyric acid or a mixture of two or more thereof. The microspheres, films and coatings so produced have improved stability in aqueous solution.
Patent JP-4620808-B2 (JP)
IPC: A61K39/00
Filed: 1995-11-28
Granted: 2011-01-26
Abstract: Vaccines comprising peptides from a fusion junction present in a mutant human EGF receptor and methods of using these vaccines in the inhibition of tumor formation and enhancement of tumor regression are provided. Cell lines which overexpress a Type III mutant EGF receptor and methods of producing these cell lines are also provided. In addition, antibodies raised against peptides expressed by these cell lines are provided. Further, antisense oligonucleotides targeted to a mutant EGF receptor which decreases expression of a mutant EGF receptor are disclosed.
Patent JP-3754083-B2 (JP)
IPC: G01D5/20
Filed: 1996-11-25
Granted: 2006-03-08
Abstract: PCT No. PCT/GB96/02896 Sec. 371 Date Sep. 25, 1998 Sec. 102(e) Date Sep. 25, 1998 PCT Filed Nov. 25, 1996 PCT Pub. No. WO97/19323 PCT Pub. Date May 29, 1997A sensor head is provided for use in a apparatus for indicating the position of a movable member relative to a fixed member. It has two multi-turn sensor windings, each including repetitive pattern of series connected alternate sense loops of conductor. One sensor winding is in spatial phase quadrature with the other sensor winding, and the arrangement of the windings is such that the mid points of the sensor windings coincide. The sensor head is particularly suited for use in indicating the position of a movable member relative to a fixed member as it is relatively insensitive to longitudinal tilt relative to the other member.
Patent JP-4121558-B2 (JP)
IPC: A61P43/00
Filed: 1996-12-11
Granted: 2008-07-23
Abstract: The present invention provides pharmaceutical compositions comprising a morphogenic protein stimulatory factor (MPSF) for improving the tissue inductive activity of morphogenic proteins, particularly those belonging to the BMP protein family. Methods for improving the tissue inductive activity of a morphogenic protein in a mammal using those compositions are provided. This invention also provides implantable morphogenic devices comprising a morphogenic protein and a MPSF disposed within a carrier, that are capable of inducing tissue formation in allogeneic and xenogeneic implants. Methods for inducing local tissue formation from a progenitor cell in a mammal using those devices are also provided. A method for accelerating allograft repair in a mammal using morphogenic devices is provided. This invention also provides a prosthetic device comprising a prosthesis coated with a morphogenic protein and a MPSF, and a method for promoting in vivo integration of an implantable prosthetic device to enhance the bond strength between the prosthesis and the existing target tissue at the joining site. Methods of treating tissue degenerative conditions in a mammal using the pharmaceutical compositions are also provided.
Patent JP-3302367-B2 (JP)
IPC: H04L12/56
Filed: 1995-03-06
Granted: 2002-07-15
Abstract: An open, high speed, high bandwidth digital communication network for connecting multiple programmable telecommunications switches to form a large capacity, non-blocking switching system. Each network switching node includes circuitry for transmitting and receiving variable-length, packetized information over the network, thus enabling each node to receive information from or transmit information to all other nodes. The network may carry any type of information present in the system including voice, data, video, multimedia, control, configuration and maintenance, and the bandwidth of the network may be divided or shared across various information types. Devices such as voice processing resources may also interface with the network, thereby gaining direct access to all information passing through the network. Also provided are methods and packet structures for communicating information over the network. Multiple networks may be interconnected to provide even greater switching capacity or voice processing capacity.
Patent JP-4226657-B2 (JP)
IPC: A61K48/00
Filed: 1997-11-26
Granted: 2009-02-18
Abstract: The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in method of diagnosis, prophylaxis, and therapy.
Patent JP-4196413-B2 (JP)
IPC: F01N3/24
Filed: 1997-03-03
Granted: 2008-12-17
Abstract: PCT No. PCT/CH97/00079 Sec. 371 Date Sep. 1, 1998 Sec. 102(e) Date Sep. 1, 1998 PCT Filed Mar. 3, 1997 PCT Pub. No. WO97/33080 PCT Pub. Date Sep. 12, 1997The invention relates to a spark ignition engine (1) having a pressure-wave supercharger (5) and a three-way catalyst (4). To remove the pollutant constituents HC, CO and NOx in an efficient manner, an oxidation catalyst (12) is connected downstream of the three-way catalyst, said oxidation catalyst being arranged between the outlet of the supercharger and the exhaust (11). The oxidation catalyst can, consequently, function with excess air which comes from the supercharger. The above combination reduces pollutants substantially with a high specific output of the engine.
Patent JP-4382164-B2 (JP)
IPC: C07D515/22
Filed: 1998-04-14
Granted: 2009-12-09
Abstract: Five new nucleophile substituted ecteinascidin compounds were isolated from extracts of  Exteinascidia turbinata  and designated Et 802, Et 788, Et 760, Et 858 and Et 815. Three new N-oxides were also obtained and designated Et 717, Et 775 and Et 789. Some of these newly discovered Et compounds show exceedingly potent cytotoxicity against L1210.
Patent AU-2002217717-B2 (AU)
Title: Combat simulation wherein target objects are associated to protecting object by means of a local co-operation between the target objects and the relevant protecting objects
Inventor: KLAHR PER
IPC: F41G3/26
Filed: 2002-01-03
Granted: 2006-11-09
Abstract: The invention relates to simulation of effects in a combat environment, wherein personnel, vehicles and buildings are exposed to simulated fire from military weapons. Direct fire and indirect fire are simulated by means of at least one of light rays and radio waves. Effects of attacking fire are registered by means of a target object device, which includes sensors adapted to detect the light rays respective the radio waves and are co-located with the target object ( 140 ). According to the invention the target object is associated to at least one protecting object located between the simulated fire and the target object if such object exists in the current combat situation. This enables a consideration to various protecting object- influence on the simulated fire and the effects on corresponding actual fire. The invention thereby simulates the effects of direct fire and indirect fire in a realistic manner, which in turn provides good chances of an adequate behavior of the training personnel in a corresponding live situation.
Patent AU-2002223343-B2 (AU)
Title: Sample introduction device for mass spectrometry using a fast fluidic system to synchronize multiple parallel liquid sample streams
Inventor: WEISS ADAM
IPC: H01J49/04
Filed: 2001-11-28
Granted: 2007-01-18
Abstract: ABSTRACT   A sample introduction device for introducing a plurality of independent fluid sample streams into a mass spectrometer includes a manifold (84) having a plurality of fluid sample stream direct paths. Each direct path extends between a fluid sample stream inlet (80, 82) and a fluid sample stream outlet. A plurality of bypass paths (92, 96) is also provided in the manifold. Each bypass path is coupled to a respective one of the direct paths between the inlet and outlet. A plurality of transfer lines (86,94) is also provided with each transfer line being coupled to a respective one of the outlets to deliver a fluid sample stream to an ionization region of the mass spectrometer. A valve (90, 96) is positioned in each of the bypass paths and is actuable to divert the fluid sample stream entering the direct path via the inlet from the direct path and into the bypass path.